Novartis AG (NVS)

88.12 +0.32  +0.36% NYSE Jul 8, 20:00 Delayed 2m USD

Novartis Total Assets (Quarterly):

123.10B for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Total Assets (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Assets (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 123.10B
Dec. 31, 2019 118.37B
Sept. 30, 2019 115.97B
June 30, 2019 116.29B
March 31, 2019 137.95B
Dec. 31, 2018 145.56B
Sept. 30, 2018 142.99B
June 30, 2018 142.06B
March 31, 2018 135.52B
Dec. 31, 2017 133.08B
Sept. 30, 2017 134.97B
June 30, 2017 133.75B
March 31, 2017 131.99B
Dec. 31, 2016 130.12B
Sept. 30, 2016 134.01B
June 30, 2016 131.44B
March 31, 2016 132.45B
Dec. 31, 2015 131.56B
Sept. 30, 2015 132.93B
June 30, 2015 135.41B
March 31, 2015 134.94B
Dec. 31, 2014 125.39B
Sept. 30, 2014 125.38B
June 30, 2014 125.77B
March 31, 2014 125.33B
   
Dec. 31, 2013 126.25B
Sept. 30, 2013 124.59B
June 30, 2013 121.07B
March 31, 2013 121.01B
Dec. 31, 2012 124.19B
Sept. 30, 2012 121.22B
June 30, 2012 118.49B
March 31, 2012 119.41B
Dec. 31, 2011 117.50B
Sept. 30, 2011 121.38B
June 30, 2011 125.92B
March 31, 2011 127.22B
Dec. 31, 2010 123.32B
Sept. 30, 2010 124.63B
June 30, 2010 96.92B
March 31, 2010 95.80B
Dec. 31, 2009 95.50B
Sept. 30, 2009 90.69B
June 30, 2009 84.27B
March 31, 2009 77.97B
Dec. 31, 2008 78.30B
Sept. 30, 2008 82.02B
June 30, 2008 83.40B
March 31, 2008 76.32B
Dec. 31, 2007 75.45B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Benchmarks

Benchmarks
AstraZeneca PLC 57.21B
Gilead Sciences Inc 59.74B
Johnson & Johnson 155.02B

Total Assets (Quarterly) Range, Past 5 Years

Minimum 115.97B Sep 2019
Maximum 145.56B Dec 2018
Average 131.79B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.